MyAverix Finance
SHG · Healthcare
Zhejiang Ausun Pharmaceutical Co Ltd (603229)
Biotechnology
Zhejiang Ausun Pharmaceutical Co Ltd (603229) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $8.33B, P/E ratio is 45.59, net margin is 24.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603229
Zhejiang Ausun Pharmaceutical Co Ltd (603229) — FAQ
What is Zhejiang Ausun Pharmaceutical Co Ltd's market cap?
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a reported market cap of $8.33B (data as of 2026-03-28).
What is 603229's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Ausun Pharmaceutical Co Ltd (603229) is 45.59 (data as of 2026-03-28).
Does Zhejiang Ausun Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Ausun Pharmaceutical Co Ltd (603229). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Ausun Pharmaceutical Co Ltd in?
Zhejiang Ausun Pharmaceutical Co Ltd (603229) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603229 listed on?
603229 is listed on SHG.
What is Zhejiang Ausun Pharmaceutical Co Ltd's net margin?
Zhejiang Ausun Pharmaceutical Co Ltd (603229) reports a net margin of 24.6% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.